Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
AcuityMD Raises $80M for AI Augmentation to Medtech Sales Platform
AcuityMD has raised $80M to advance its provision for assisting medtech companies in accelerating the adoption of their products across healthcare settings and geographic markets.
The Boston-based company’s Series C financing round was led by existing investor StepStone Group. VC firms Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management also participated.
Used by 16 of the top 20 medtech companies, AcuityMD’s platform identifies metrics including physicians, facilities, networks, procedures, and reimbursement dynamics. Aggregating this data alongside medtech companies’ internal data, including contracting information, product indications, territory structure, and CRM activity, companies can better estimate commercial execution and reach the right end markets for their products.
With the fresh funding in hand, which brings AcuityMD’s total funding to date to over $160m, the company plans to augment its existing platform with artificial intelligence (AI) with the launch of AcuityAI. According to AcuityMD, its AI platform’s overall aim is to avail medtech company sales representatives with more streamlined insights.
As well as advancing its AI capabilities, AcuityMD also intends to use the funding towards deepening the medtech ontology of its data model, and to expand the platform beyond commercial pursuits, with a view to accelerating adoption across the full product lifecycle.
AcuityMD CEO, Mike Monovoukas, commented, “AI will transform medtech, but only with the right context, deeply embedded in the workflows where decisions are made. AcuityMD is that context layer, serving the rep in the field, the commercial leader planning territories, and the teams launching the next generation of innovation.”
AI is having an appreciable impact on driving efficiencies in the broader healthcare space…
Full release here, originally announced April 22nd, 2026.
Almanac Health Raises $10 Million to Empower Clinicians Across Specialties with Safe, Research-Validated Clinical AI
Seed Round Led by F-Prime, with Participation from General Catalyst and Lightspeed Venture Partners; General Catalyst Previously Led the Pre-Seed Round
Almanac Health, a research-validated clinical AI platform and evidence-based clinical decision support company founded by physician-researcher Cyril Zakka, MD, whose work at Stanford introduced retrieval-augmented generation to clinical medicine, has raised $10 million in a seed round led by F-Prime, with participation from General Catalyst and Lightspeed Venture Partners. General Catalyst previously led the company’s pre-seed round with participation from Soma Capital. This financing brings Almanac Health’s total funding to nearly $12 million and will accelerate the company’s mission to bring safe, evidence-grounded AI to clinicians and health systems.
Almanac Health is a unified clinical AI platform for clinical decision support that brings specialist-grade knowledge to every clinician at the point of care. It is designed to work within existing electronic health record (EHR) systems, governed by institutional controls, and grounded in peer-reviewed evidence. The platform is currently undergoing rigorous clinical validation in academic medical center settings.
“There is no shortage of technologies promising to transform medicine. But few are grounded in real evidence, built with integrity, and deserving of trust from the people and organizations using them. Almanac Health’s goal is to build clinical AI held to that standard. Validated through research, with incentives aligned with clinicians and patients. We’re focused on getting that right,” said Cyril Zakka, MD, Founder and CEO at Almanac Health.
Cyril Zakka, MD, has worked at the intersection of medicine and AI across clinical practice, academic research, and industry. After earning his MD, he went on to conduct machine learning research at Stanford, where he developed the first retrieval-augmented generation system for clinical medicine, an approach to grounding AI in trusted medical knowledge that has since been widely adopted across clinical AI. That work, published in NEJM AI, became one of the journal’s most-cited papers and established the foundational approach used by most clinical evidence AI products today. He subsequently led health AI at Hugging Face, the largest open-source AI platform, before founding Almanac Health.
“Cyril is one of the rare founders who has both the clinical training and the technical depth to build AI that clinicians will actually trust, as well as the discipline to validate it before deploying it. Almanac Health represents what we believe the next generation of healthcare AI should look like: grounded in research, governed by institutions, and built with incentives that put clinicians and patients first,” said Carl Byers, Partner at F-Prime.
The funding will allow the company to grow its team across clinical medicine…
Full release here, originally announced April 23rd, 2026.
No comments:
Post a Comment